BBB Therapeutics logo

BBB Therapeutics

Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barrier

21 employees · est. 2003 · Leiden, The Netherlands

VS
Enterome logo

Enterome

Delivering the promise of immunotherapy

49 employees · est. 2011 · Paris, France

BBB Therapeutics is the older company (2003 vs 2011).

Side-by-Side Comparison

BBB Therapeutics Enterome
Founded
2003 older 2011
Headquarters
Leiden, The Netherlands Paris, France
Employees
21 49
Industry
Biopharma, Biotechnology, Pharmaceutical Biopharma, Biotechnology, Health Care
Funding Stage
Unknown Series Unknown
Total Funding
$21.00M $175.80M
Funding Rounds
7 9
Services
Not tracked yet Development of off-the-shelf cancer immunotherapy treatments
Target Customers
Not tracked yet Patients with B cell malignancies, Glioblastoma, adrenal tumors, and colorectal cancer
Taxonomy
Clinical Stage, Brain Disorders, Brain Cancer, Neuroinflammatory Diseases, Drug Development, G-Technology, Drug Delivery, Blood-brain Barrier, Clinical Trials, 2B3-101, 2B3-201, Phase IIa Trial, Phase I Clinical Study, Treatment Immunotherapy, Biopharmaceuticals, Drug Discovery, OncoMimics, Cancer Treatment, Immunomodulatory Drugs, Phase 2 Clinical Trials, Tumor Associated Antigens, CD8 T Cell Response, Glioblastoma, Adrenal Malignancies, Colorectal Cancer, Clinical-stage Biotech, Immunotherapies, Metagenomics
Website
bbbtherapeutics.com enterome.com
BBB Therapeutics logo

About BBB Therapeutics

BBB Therapeutics, founded in 2003 and headquartered in The Netherlands, is a clinical stage biotechnology company that has carved a niche in developing treatments for critical brain disorders, including brain cancer and neuroinflammatory diseases. The company leverages its proprietary G-TechnologyĂ...

Enterome logo

About Enterome

Enterome is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in France. It focuses on delivering the promise of immunotherapy through the development of breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. The company's unique approach to d...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at BBB Therapeutics and Enterome — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at BBB Therapeutics and Enterome — by email.

Frequently Asked Questions

BBB Therapeutics — Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barrier. Enterome — Delivering the promise of immunotherapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BBB Therapeutics has raised $21.00M while Enterome has raised $175.80M.
BBB Therapeutics and Enterome operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BBB Therapeutics with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy